AI/ML Innovations Inc. has appointed Erik Suokas as Chief Operating Officer to enhance commercial execution and operational scale. Erik Suokas will oversee AIML?s day-to-day operations and execution across commercial strategy, contract discipline, delivery readiness, and cross-functional alignment. He will work closely with Paul Duffy, Executive Chairman & Chief Executive Officer, and Esmat Naikyar, Chief Product Officer, to convert growing commercial momentum into repeatable revenue and scalable delivery.
Erik Suokas brings more than 20 years of leadership experience across healthcare, MedTech, SaaS, and regulated clinical environments, with a consistent track record of building teams, accelerating revenue, and operationalizing growth in complex, cross-border markets. Most recently, Erik Suokas served as National Director at Sun Nuclear North America, a leading provider of quality assurance and software solutions for radiation oncology and medical physics, where he launched the Canadian direct-sales organization and drove approximately 200% revenue growth in under two years by transitioning the business from a distributor-based model to a direct enterprise sales approach. Earlier in his career, Erik Suokas held senior commercial and operational roles at Canadian Orthodontic Partners, supporting acquisitions and integration across Canada and the United States, as well as leadership positions at Abbott Medical, St.
Jude Medical, Align Technology, and Medtronic. His experience spans cardiology, diagnostics, enterprise healthcare procurement, and regulated market delivery. Erik Suokas holds a Doctor of Chiropractic (DC), Juris Doctor (JD), and MBA.
